|
|
Line 3: |
Line 3: |
| <StructureSection load='6uex' size='340' side='right'caption='[[6uex]], [[Resolution|resolution]] 1.90Å' scene=''> | | <StructureSection load='6uex' size='340' side='right'caption='[[6uex]], [[Resolution|resolution]] 1.90Å' scene=''> |
| == Structural highlights == | | == Structural highlights == |
- | <table><tr><td colspan='2'>[[6uex]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Staan Staan]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6UEX OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6UEX FirstGlance]. <br> | + | <table><tr><td colspan='2'>[[6uex]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Staphylococcus_aureus_subsp._aureus_N315 Staphylococcus aureus subsp. aureus N315]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6UEX OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=6UEX FirstGlance]. <br> |
- | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=Q5S:2-(acetylamino)-2-deoxy-1-O-[(S)-hydroxy{[(S)-hydroxy{[(2Z,6Z,10Z,14Z,18Z,22Z,26Z)-3,7,11,15,19,23,27,31-octamethyldotriaconta-2,6,10,14,18,22,26,30-octaen-1-yl]oxy}phosphoryl]oxy}phosphoryl]-alpha-D-glucopyranose'>Q5S</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr> | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.9Å</td></tr> |
- | <tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">msrR, SA1195 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=158879 STAAN])</td></tr>
| + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=Q5S:2-(acetylamino)-2-deoxy-1-O-[(S)-hydroxy{[(S)-hydroxy{[(2Z,6Z,10Z,14Z,18Z,22Z,26Z)-3,7,11,15,19,23,27,31-octamethyldotriaconta-2,6,10,14,18,22,26,30-octaen-1-yl]oxy}phosphoryl]oxy}phosphoryl]-alpha-D-glucopyranose'>Q5S</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr> |
- | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6uex FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6uex OCA], [http://pdbe.org/6uex PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6uex RCSB], [http://www.ebi.ac.uk/pdbsum/6uex PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6uex ProSAT]</span></td></tr> | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=6uex FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6uex OCA], [https://pdbe.org/6uex PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=6uex RCSB], [https://www.ebi.ac.uk/pdbsum/6uex PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=6uex ProSAT]</span></td></tr> |
| </table> | | </table> |
| == Function == | | == Function == |
- | [[http://www.uniprot.org/uniprot/MSRR_STAAN MSRR_STAAN]] Involved in SarA attenuation. Affects resistance to oxacillin and teicoplanin, as well as the synthesis of virulence factors (By similarity). | + | [https://www.uniprot.org/uniprot/MSRR_STAAN MSRR_STAAN] Involved in SarA attenuation. Affects resistance to oxacillin and teicoplanin, as well as the synthesis of virulence factors (By similarity). |
| <div style="background-color:#fffaf0;"> | | <div style="background-color:#fffaf0;"> |
| == Publication Abstract from PubMed == | | == Publication Abstract from PubMed == |
Line 24: |
Line 24: |
| </StructureSection> | | </StructureSection> |
| [[Category: Large Structures]] | | [[Category: Large Structures]] |
- | [[Category: Staan]] | + | [[Category: Staphylococcus aureus subsp. aureus N315]] |
- | [[Category: Li, F K.K]] | + | [[Category: Li FKK]] |
- | [[Category: Strynadka, N C.J]] | + | [[Category: Strynadka NCJ]] |
- | [[Category: Cpsa]]
| + | |
- | [[Category: Lytr]]
| + | |
- | [[Category: Psr]]
| + | |
- | [[Category: Transferase]]
| + | |
| Structural highlights
Function
MSRR_STAAN Involved in SarA attenuation. Affects resistance to oxacillin and teicoplanin, as well as the synthesis of virulence factors (By similarity).
Publication Abstract from PubMed
Gram-positive bacteria, including major clinical pathogens such as Staphylococcus aureus, are becoming increasingly drug-resistant. Their cell wall is composed of a thick layer of peptidoglycan (PG) modified by the attachment of wall teichoic acid (WTA), an anionic glycopolymer that is linked to pathogenicity and regulation of cell division and PG synthesis. The transfer of WTA from lipid carriers to PG, catalyzed by the LytR-CpsA-Psr (LCP) enzyme family, offers a unique extracellular target for the development of new anti-infective agents. Inhibitors of LCP enzymes have the potential to manage a wide range of bacterial infections as the target enzymes are implicated in the assembly of many other bacterial cell wall polymers including capsular polysaccharide of streptococcal species and arabinogalactan of mycobacterial species. In this study, we present the first crystal structure of S. aureus LcpA with bound substrate at 1.9 A resolution and those of Bacillus subtilis LCP enzymes, TagT, TagU and TagV, in the apo form at 1.6-2.8 A resolution. The structures of these WTA transferases provide new insight into the binding of lipid-linked WTA and enable assignment of the catalytic roles of conserved active site residues. Furthermore, we identified potential subsites for binding the saccharide core of PG using computational docking experiments, and multi-angle light scattering experiments disclosed novel oligomeric states of the LCP enzymes. The crystal structures and modeled substrate-bound complexes of the LCP enzymes reported here provide insights into key features linked to substrate binding and catalysis and may aid the structure-guided design of specific LCP inhibitors.
Crystallographic analysis of Staphylococcus aureus LcpA, the primary wall teichoic acid ligase.,Li FKK, Rosell FI, Gale RT, Simorre JP, Brown ED, Strynadka NCJ J Biol Chem. 2020 Jan 22. pii: RA119.011469. doi: 10.1074/jbc.RA119.011469. PMID:31969390[1]
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
References
- ↑ Li FKK, Rosell FI, Gale RT, Simorre JP, Brown ED, Strynadka NCJ. Crystallographic analysis of Staphylococcus aureus LcpA, the primary wall teichoic acid ligase. J Biol Chem. 2020 Jan 22. pii: RA119.011469. doi: 10.1074/jbc.RA119.011469. PMID:31969390 doi:http://dx.doi.org/10.1074/jbc.RA119.011469
|